Upstream Bio has swollen its IPO to $255 million as the company joins CAMP4 Therapeutics this morning in becoming the latest ...

A new report identifies six Massachusetts startup "unicorns" as life science companies most likely to hold initial public ...

It will be targeted at institutional investors in the UK as well as retail investors through the Retail Book platform.

Three US life-sciences companies hitting the market delivered mostly robust early trading after investors strongly supported ...

A combination of strong growth, backed by a robust pipeline of projects, and relatively higher return ratios mean better ...

Biotech IPO activity in the US has spiked for the second time this year, following an initial boost in Q1 2024. Largely ...

Two biotechs set out for the public markets this week, with Upstream Bio raising $255 million for its inflammatory disease ...

India's scrapping of a time-consuming compliance step will accelerate the pace at which Indian startups domiciled abroad ...

Cerebras competes with industry leader Nvidia in the lucrative artificial intelligence chip market. The Sunnyvale, California ...

Japanese payments company Infcurion is planning an initial public offering in Tokyo in 2025 as the company looks to ...

Hyundai Motor plans to use proceeds from a record $3.3 billion IPO of its Indian unit to enhance its research efforts and ...

The family-owned company will continue to evaluate the possibility of listing its shares once the situation improves.